Document is current
Any future updates will be listed below
-
Authors
Rubio-Perez, Carlota https://orcid.org/0000-0002-1921-168X
Planas-Rigol, Ester
Trincado, Juan L. https://orcid.org/0000-0001-5363-3774
Bonfill-Teixidor, Ester https://orcid.org/0000-0002-9260-448X
Arias, Alexandra
Marchese, Domenica
Moutinho, Catia
Serna, Garazi https://orcid.org/0000-0003-2666-0982
Pedrosa, Leire
Iurlaro, Raffaella
Martínez-Ricarte, Francisco
Escudero, Laura https://orcid.org/0000-0001-7385-673X
Cordero, Esteban
Cicuendez, Marta
Ruiz, Sara
Parra, Genís
Nuciforo, Paolo https://orcid.org/0000-0003-1380-0990
Gonzalez, Josep
Pineda, Estela
Sahuquillo, Juan https://orcid.org/0000-0003-0713-5875
Tabernero, Josep https://orcid.org/0000-0002-2495-8139
Heyn, Holger https://orcid.org/0000-0002-3276-1889
Seoane, Joan https://orcid.org/0000-0002-6541-5974
- License Information
-
More Information
Article History
Received: 12 August 2020
Accepted: 10 February 2021
First Online: 8 March 2021
Competing interests
: J.S. is co-founder of Mosaic Biomedicals and has ownership interests from Mosaic Biomedicals and Northern Biologics. J.S. received grant/research support from Mosaic Biomedicals, Northern Biologics, Roche/Glycart, and Hoffmann la Roche. J.S. declares scientific consultancy role for Merck Serono, GSK, Eli Lilly. J.T. declares scientific consultancy role for Array Biopharma, AstraZeneca, Bayer, BeiGene, Boehringer Ingelheim, Chugai, Genentech Inc., Genmab A/S, Halozyme, Imugene Limited, Inflection Biosciences Limited, Ipsen, Kura Oncology, Lilly, MSD, Menarini, Merck Serono, Merrimack, Merus, Molecular Partners, Novartis, Peptomyc, Pfizer, Pharmacyclics, ProteoDesign SL, Rafael Pharmaceuticals, F. Hoffmann–La Roche Ltd., Sanofi, SeaGen, Seattle Genetics, Servier, Symphogen, Taiho, VCN Biosciences, Biocartis, Foundation Medicine, HalioDX SAS, and Roche Diagnostics. E.P. declares scientific consultancy role for Celgene. P.N. declares scientific consultancy role for Bayer, Novartis and Merck Sharp and Dohme. The other authors declare no competing interests.
